29 results on '"Magavern, Emma F."'
Search Results
2. SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort
3. Use of Genomics to Develop Novel Therapeutics and Personalize Hypertension Therapy
4. Factor V Leiden, estrogen, and multimorbidity association with venous thromboembolism in a British-South Asian cohort
5. CYP2C19 Genotype Prevalence and Association With Recurrent Myocardial Infarction in British–South Asians Treated With Clopidogrel
6. Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era
7. Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data
8. UK Prescribing Safety Assessment (PSA): The development, implementation and outcomes of a national online prescribing assessment
9. Factor V Leiden, oestrogen and multimorbidity association with venous thromboembolism in a British-South Asian Cohort
10. UK Prescribing Safety Assessment (PSA): The development, implementation and outcomes of a national online prescribing assessment.
11. An Academic Clinician’s Road Map to Hypertension Genomics: Recent Advances and Future Directions MMXX
12. CYP2C19 loss of function alleles are not associated with higher prevalence of gastrointestinal bleeds in those who have been prescribed antidepressants: Analysis in a British‐South Asian cohort
13. Equal access to pharmacogenomics testing: The ethical imperative for population‐wide access in the UK NHS
14. SLCO1B1*5is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort
15. Prescribing direct‐acting oral anticoagulants – Mind the evidence gap
16. Pharmacogenomics: Relevance and opportunities for clinical pharmacology
17. Ethics in clinical pharmacology: Facilitating public trust
18. Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
19. Health equality, race and pharmacogenomics
20. Pharmacogenomics spotlight commentary: From the United Kingdom to global populations
21. Introduction to clinical pharmacology at large
22. Health equality, race and pharmacogenomics.
23. Omega-3 fatty acid supplementation does not prevent serious vascular events in people with diabetes
24. Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
25. Ethical considerations for genetic testing in the context of mandated cardiac screening before athletic participation
26. Ethics in clinical pharmacology: Facilitating public trust.
27. CYP2C19 genetic testing for Mavacamten and ischaemic stroke treatment: What does the result mean for cardiovascular prescribers in the UK and Europe?
28. Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data.
29. Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.